Purchase Order 75N92B23P00011

This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Air Force Materiel Command to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for the development of passive nanoparticle coatings with high visible luminous transmittance and near-infrared blocking capabilities. Nanocomposix has prior experience as both a prime contractor and subcontractor on federal contracts, including work for the Department of...

<p>This is a $750,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Air Force Materiel Command to Nanocomposix, Inc., a manufacturer of engineered nanoparticles, for the development of passive nanoparticle coatings. Nanocomposix has previously provided products and services to other federal agencies such as the Department of Health and Human Services and the Department of Defense. This contract is set aside for small businesses.</p>

This is a $999,999.99 cost-plus-fixed-fee contract awarded by the U.S. Army Medical Command (MEDCOM) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for a Small Business Innovation Research (SBIR) Phase II program with a target completion date of February 27, 2019. Nanocomposix has previously supported the Department of Defense and Department of Health and Human Services through prime federal contracts and subcontracts, delivering products and...

The Department of the Army Materiel Command Research Development and Engineering Command awarded a $167,500.00 Firm Fixed Price contract to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles, to develop drying processes for producing high aspect ratio conductive flakes using physical vapor deposition. This Small Business Innovation Research (SBIR) Program Phase I action contract was awarded on May 19, 2020, with a completion date of March 19, 2021. Nanocomposix has...

This is a $1,000,000.00 Phase II SBIR contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for the rapid screening of individual cells using single cell mass spectrometry, supporting the NCI's biomedical research and development efforts. Nanocomposix has previously supported other federal agencies such as the Department of Defense...

This is a $150,000.00 firm fixed-price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract has a period of performance ending on March 30, 2016. Nanocomposix has provided similar products and services to the Department of Health and Human Services and Department of Defense in the past, including lateral flow assay devices, gold nanoparticles, and research and development for...

This is a Small Business Innovation Research (SBIR) Phase I contract award to Nanocomposix, Inc. by the U.S. Army Medical Command (MEDCOM) for the development of new biomedical technologies. The contract has a firm fixed price of $150,000.00 and a period of performance through March 25, 2017. Nanocomposix, a manufacturer of engineered nanoparticles, has previously received prime federal contracts and grants from agencies such as the Department of Health and Human Services and Department of...

This is a Phase I Small Business Technology Transfer (STTR) contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Nanocomposix, Inc., a for-profit manufacturer of engineered nanoparticles. The $150,000.00 firm fixed price contract was awarded on June 23, 2017 with a completion date of March 31, 2018. Nanocomposix has previously received prime federal contracts from agencies such as the Department of Health and Human Services and...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract, valued at $199,981, is for the development of nanoparticle-enabled single cell mass spectrometry technology for the detection of rare cells, under SBIR Topic 266. As a small business, Nanocomposix has been awarded previous prime...

This SBIR Phase II contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The $997,267 cost-plus-fixed-fee contract is for the development of &quot;bright, photostable surface enhanced fluorescent nanotags&quot; to advance biomedical technologies. Nanocomposix has previously provided products and R&amp;D services to NCI, FDA, CDC, and the...